Mid-Illinois Hematology Oncology Associates Limited is a clinical research site located in Normal, Illinois, United States 61761.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
Mid-Illinois Hematology Oncology Associates Limited has participated in 7 clinical trials with 4 currently active.
Therapeutic areas: Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma.
Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Normal
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mid-Illinois Hematology Oncology Associates Limited has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mid-Illinois Hematology Oncology Associates Limited has 7 clinical trials on record, with 4 currently active. Their work covers Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma.
Mid-Illinois Hematology Oncology Associates Limited has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.